2023 Ludvik B, Giorgino F, Jodar E et al (2021) Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
During this phase, you might also notice improvements beyond weight loss
Second, remove the pen from the refrigerator and let it reach room temperature for 15 to 30 minutes before injecting
"My doctor truly listened to me, adjusting my medication to fit my specific needs
Peptide treatments should only be administered under the supervision of a qualified, licensed healthcare provider
In December 2025, Eli Lilly announced topline results from the phase-3 TRIUMPH-4 clinical trial evaluating the safety and efficacy of retatrutide in adults with obesity or overweight and knee osteoarthritis, and without diabetes, as an adjunct to healthy diet and physical activity